TP53 and lymphoma: Interestingly, despite TP53 mutations typically predicting poorer prognosis in lymphomas, C1, predominantly featuring TP53 mutations in PTL, exhibits improved PFS and OS (Fig. 2C, OS, P = 0.01, PFS, P = 0.045).